Cargando…

Ginsenoside 20(S)-Rg3 Targets HIF-1α to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells

The prognosis of patients with ovarian cancer has remained poor mainly because of aggressive cancer progression. Since epithelial-mesenchymal transition (EMT) is an important mechanism mediating invasion and metastasis of cancer cells, targeting the EMT process with more efficacious and less toxic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ting, Zhao, Le, Zhang, Yan, Chen, Wei, Liu, Dan, Hou, Huilian, Ding, Lu, Li, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157750/
https://www.ncbi.nlm.nih.gov/pubmed/25197976
http://dx.doi.org/10.1371/journal.pone.0103887
_version_ 1782333922898608128
author Liu, Ting
Zhao, Le
Zhang, Yan
Chen, Wei
Liu, Dan
Hou, Huilian
Ding, Lu
Li, Xu
author_facet Liu, Ting
Zhao, Le
Zhang, Yan
Chen, Wei
Liu, Dan
Hou, Huilian
Ding, Lu
Li, Xu
author_sort Liu, Ting
collection PubMed
description The prognosis of patients with ovarian cancer has remained poor mainly because of aggressive cancer progression. Since epithelial-mesenchymal transition (EMT) is an important mechanism mediating invasion and metastasis of cancer cells, targeting the EMT process with more efficacious and less toxic compounds to inhibit metastasis is of great therapeutic value for the treatment of ovarian cancer. We have found for the first time that the ginsenoside 20(S)-Rg3, a pharmacologically active component of the traditional Chinese herb Panax ginseng, potently blocks hypoxia-induced EMT of ovarian cancer cells in vitro and in vivo. Mechanistic studies confirm the mode of action of 20(S)-Rg3, which reduces the expression of hypoxia-inducible factor 1α (HIF-1α) by activating the ubiquitin-proteasome pathway to promote HIF-1α degradation. A decrease in HIF-1α in turn leads to up-regulation, via transcriptional suppression of Snail, of the epithelial cell-specific marker E-cadherin and down-regulation of the mesenchymal cell-specific marker vimentin under hypoxic conditions. Importantly, 20(S)-Rg3 effectively inhibits EMT in nude mouse xenograft models of ovarian cancer, promising a novel therapeutic agent for anticancer therapy.
format Online
Article
Text
id pubmed-4157750
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41577502014-09-09 Ginsenoside 20(S)-Rg3 Targets HIF-1α to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells Liu, Ting Zhao, Le Zhang, Yan Chen, Wei Liu, Dan Hou, Huilian Ding, Lu Li, Xu PLoS One Research Article The prognosis of patients with ovarian cancer has remained poor mainly because of aggressive cancer progression. Since epithelial-mesenchymal transition (EMT) is an important mechanism mediating invasion and metastasis of cancer cells, targeting the EMT process with more efficacious and less toxic compounds to inhibit metastasis is of great therapeutic value for the treatment of ovarian cancer. We have found for the first time that the ginsenoside 20(S)-Rg3, a pharmacologically active component of the traditional Chinese herb Panax ginseng, potently blocks hypoxia-induced EMT of ovarian cancer cells in vitro and in vivo. Mechanistic studies confirm the mode of action of 20(S)-Rg3, which reduces the expression of hypoxia-inducible factor 1α (HIF-1α) by activating the ubiquitin-proteasome pathway to promote HIF-1α degradation. A decrease in HIF-1α in turn leads to up-regulation, via transcriptional suppression of Snail, of the epithelial cell-specific marker E-cadherin and down-regulation of the mesenchymal cell-specific marker vimentin under hypoxic conditions. Importantly, 20(S)-Rg3 effectively inhibits EMT in nude mouse xenograft models of ovarian cancer, promising a novel therapeutic agent for anticancer therapy. Public Library of Science 2014-09-08 /pmc/articles/PMC4157750/ /pubmed/25197976 http://dx.doi.org/10.1371/journal.pone.0103887 Text en © 2014 Liu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Liu, Ting
Zhao, Le
Zhang, Yan
Chen, Wei
Liu, Dan
Hou, Huilian
Ding, Lu
Li, Xu
Ginsenoside 20(S)-Rg3 Targets HIF-1α to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells
title Ginsenoside 20(S)-Rg3 Targets HIF-1α to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells
title_full Ginsenoside 20(S)-Rg3 Targets HIF-1α to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells
title_fullStr Ginsenoside 20(S)-Rg3 Targets HIF-1α to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells
title_full_unstemmed Ginsenoside 20(S)-Rg3 Targets HIF-1α to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells
title_short Ginsenoside 20(S)-Rg3 Targets HIF-1α to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells
title_sort ginsenoside 20(s)-rg3 targets hif-1α to block hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157750/
https://www.ncbi.nlm.nih.gov/pubmed/25197976
http://dx.doi.org/10.1371/journal.pone.0103887
work_keys_str_mv AT liuting ginsenoside20srg3targetshif1atoblockhypoxiainducedepithelialmesenchymaltransitioninovariancancercells
AT zhaole ginsenoside20srg3targetshif1atoblockhypoxiainducedepithelialmesenchymaltransitioninovariancancercells
AT zhangyan ginsenoside20srg3targetshif1atoblockhypoxiainducedepithelialmesenchymaltransitioninovariancancercells
AT chenwei ginsenoside20srg3targetshif1atoblockhypoxiainducedepithelialmesenchymaltransitioninovariancancercells
AT liudan ginsenoside20srg3targetshif1atoblockhypoxiainducedepithelialmesenchymaltransitioninovariancancercells
AT houhuilian ginsenoside20srg3targetshif1atoblockhypoxiainducedepithelialmesenchymaltransitioninovariancancercells
AT dinglu ginsenoside20srg3targetshif1atoblockhypoxiainducedepithelialmesenchymaltransitioninovariancancercells
AT lixu ginsenoside20srg3targetshif1atoblockhypoxiainducedepithelialmesenchymaltransitioninovariancancercells